for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CONMED Corporation

CNMD.OQ

Latest Trade

113.00USD

Change

0.00(0.00%)

Volume

93,078

Today's Range

112.36

 - 

114.00

52 Week Range

57.38

 - 

114.51

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
113.00
Open
113.27
Volume
93,078
3M AVG Volume
4.72
Today's High
114.00
Today's Low
112.36
52 Week High
114.51
52 Week Low
57.38
Shares Out (MIL)
28.37
Market Cap (MIL)
3,206.83
Forward P/E
42.88
Dividend (Yield %)
0.71

Next Event

Conmed Corp at Jefferies London Healthcare Conference

Latest Developments

More

Conmed Reports Q3 GAAP Earnings Per Share Of $0.23

Conmed Corp Announces Second Quarter Earnings Per Share Of $0.19

Conmed Corporation Q1 GAAP Earnings Per Share $0.04

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CONMED Corporation

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical smoke evacuation products. As of December 31, 2018, the Company's products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company's orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Industry

Medical Equipment & Supplies

Contact Info

525 French Rd

+1.315.6243208

http://www.conmed.com/

Executive Leadership

Mark E. Tryniski

Independent Chairman of the Board

Curt R. Hartman

President, Chief Executive Officer, Director

Todd W. Garner

Chief Financial Officer, Executive Vice President

Patrick J. Beyer

President of CONMED International

Daniel S. Jonas

Executive Vice President-Legal Affairs, General Counsel, Secretary

Key Stats

2.14 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.8K

2017

0.8K

2018

0.9K

2019(E)

1.0K
EPS (USD)

2016

1.840

2017

1.890

2018

2.180

2019(E)

2.635
Price To Earnings (TTM)
115.32
Price To Sales (TTM)
3.44
Price To Book (MRQ)
4.57
Price To Cash Flow (TTM)
32.12
Total Debt To Equity (MRQ)
113.30
LT Debt To Equity (MRQ)
111.38
Return on Investment (TTM)
2.05
Return on Equity (TTM)
1.84

Latest News

Latest News

BRIEF-Conmed Corporation Q1 GAAP Earnings Per Share $0.37

* CONMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Conmed Q4 Earnings Per Share $1.65

* ORATION ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

BRIEF-Conmed Corp Appoints Todd W. Garner As CFO

* CONMED CORPORATION APPOINTS TODD W. GARNER AS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-Conmed Corp announces retirement of CFO ‍Luke A. Pomilio

* Conmed Corp announces retirement of chief financial officer

BRIEF-Conmed Corp reports Q3 adjusted earnings per share $0.42

* Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S

BRIEF-Conmed Corporation Q2 earnings per share $0.22

* Conmed Corporation announces second quarter 2017 financial results

BRIEF-MedShape sells ExoShape ACL product line to CONMED Corp

* Medshape sells exoshape® acl product line to conmed corporation

BRIEF-Conmed Corp reports Q1 adjusted earnings per share $0.38

* Conmed Corporation announces first quarter 2017 financial results

BRIEF-Lexion Medical says a jury found unit of CONMED Corp liable for false advertising

* Jury awards $10 million in punitive damages against SurgiQuest, a subsidiary of CONMED Corporation for false advertising in dispute with Lexion Medical

BRIEF-Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages

* Conmed corporation announces jury verdict in delaware litigation against surgiquest

BRIEF-Conmed Q4 adjusted earnings per share $0.54

* Conmed Corporation announces fourth quarter and fiscal year 2016 financial results

BRIEF-Bovie medical announces sales partnership with CONMED for PlazXact

* Bovie Medical announce sales channel partnership with conmed for plazxact(tm)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up